Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinomaYing Jiang, Fuchu He, Baocai Xing et al.|Nature|2019Cited by 982
CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B CellsLei Tao, Wenzheng Jiang, Muhammad Asad Farooq et al.|Cancers|2020Cited by 36
A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based studyLi Zhang, Zuo‐Lin Xiang|Journal of Cancer|2019Cited by 14